Characterization of a fibrin glue-GDNF slow-release preparation

Cell Transplantation

Volumn 7, Issue 1, 1998, Pages 53-61

  Cheng, Henrich ^a,d   Fraidakis, Matt ^a   Blombäck, Birger ^a   Lapchak, Paul ^b   Hoffer, Barry ^c   Olson, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b AMGEN INC   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Fibrin glue; GDNF; Slow release; Spinal cord

Indexed keywords

FIBRIN GLUE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IODINE 125;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG IMPLANTATION; DRUG RELEASE; FEMALE; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SLOW RELEASE FORMULATION; SPINAL CORD; STATISTICAL ANALYSIS;

ANIMALS; ANTERIOR CHAMBER; AUTORADIOGRAPHY; DELAYED-ACTION PREPARATIONS; FEMALE; FIBRIN TISSUE ADHESIVE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IODINE RADIOISOTOPES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TISSUE ADHESIVES;

EID: 0031893080     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00122-X     Document Type: Article

References (42)

1. Andres, J.; DeFalcis, D.; Noda, M.; Massague, J. Binding of two growth factor families to separate domains of the proteoglycan betaglycan. J. Biol. Chem. 267:5927-5930; 1992.
2. Barkalow, F.; Schwarzbauer, J. Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 266: 7812-7818; 1991.
3. Beckmann, R.; Geiger, M.; de Vries, C.; Pannekoek, H.; Binder, B. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator. J. Biol. Chem. 266: 2227-2232; 1991.
4. Blombäck, B.; Banerjee, D.; Carlsson, K.; Hamsten, A.; Hessel, B.; Procyk, R.; Silverira, A.; Zacharski, L. Native fibrin gel networks and factors influencing their formation in health and disease. In: Liu, C.Y., ed. Fibrinogen, thrombosis, coagulation, and fibrinolysis. New York: Plenum; 1990:1-23.
5. Blombäck, B.; Carlsson, K.; Fatah, K.; Hessel, B.; Proczk, R. Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb. Res. 75:521-538; 1994.
6. Cao, Y. Expression of acidic fibroblast growth factor in vitro and in the brain. Ph.D. Thesis, Ludwig Institute for Cancer Research, Stockholm Branch and Dept. of Physiological Chemistry, Karolinska Institute, Stockholm, Sweden; 1993.
7. Cheng, H.; Hoffer, B.; Strömberg, I.; Russell, D.; Olson, L. The effect of glial cell line-derived neurotrophic factor in fibrin glue on developing dopamine neurons. Exp. Brain Res. 104:199-206; 1995.
8. Cheng, H.; Almström, S.; Olson, L. Fibrin glue used as an adhesive agent in CNS tissues. J. Neura. Transplant. Plast. 5:233-243; 1995.
9. Cheng, H.; Cao, Y.; Olson, L. Spinal cord repair in adult paraplegic rats: Partial restoration of hindlimb function. Science 273:510-513; 1996.
10. Cordeiro, P.; Seckel, B.; Lipton, S.; D'Amore, P.; Wagner, J.; Madison, R. Acidic FGF enhances peripheral nerve regeneration in vivo. Plastic Reconstruct. Surg. 83:1013-1019; 1989.
11. Doolitte, R. Fibrinogen and fibrin. Annu. Rev. Biochem. 53:195-229; 1984.
12. Gash, D.; Zhang, Z.; Ovadia, A.; Cass, W.; Yi, A.; Simmerman, L.; Russell, D.; Martin, D.; Lapchak, P.; Collins, F.; Hoffer, B.; Gerhardt, G. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252-255; 1996.
13. Hedman, K.; Johansson, S.; Vartio, T.; Kjellen, L.; Vaheri, A.; Hook, M. Structure of the pericellular matrix: Association of heparin and chondroitin sulfates with fibronectin-procollagen fibers. Cell 28:663-671; 1982.
14. Henderson, C.; Phillips, H.; Pollock, R.; Davies, A.; Lemeulle, C.; Armanini, M.; Simmons, L.; Moffet, B.; Vandlen, R.; Simpson, L. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-1064; 1994.
15. Hoffman, D.; Breakefield, X.; Short, M.; Aebischer, P. Transplantation of a polymer/encapsulated cell line genetically engineered to release NGF. Exp. Neurol. 122:100-106; 1993.
16. Ingham, K.; Brew, S.; Atha, D. Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem. J. 272:605-611; 1990.
17. Jessell, T. Cell migration and axon guidance. In: Kandel, E.R.; Schwartz, J.H.; Jessell, T.M., eds. Principles of neural science. New York: Elsevier, 1991:909-928.
18. Johansson, S. Noncollagenous proteins of the extracelluar matrix. In: Comper, W., ed.. Structure and function of the extracellular matrix of connective tissues. Australia: Gordon and Breach Science Publishers; 1995:1-46.
19. Johnson, O.; Cleland, J.; Lee, H.; Charnis, M.; Duenas, E.; Jaworowwicz, W.; Shepard, D.; Shahzamani, A.; Jones, A.; Putney, S. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2:795-799; 1996.
20. Kan, M.; Shi, E. Fibronectin, not Iaminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth. In Vitro Cell Dev. Biol. 26:1151-1156; 1990.
21. Kan, M.; Wang, F.; Xu, J.; Crabb, J.; Hou, J.; McKeenhan, W. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259:1918-1921; 1993.
22. Knoops, B.; Hubert, I.; Hauw, J.; van den Bosch de Aguila, P. Axonal growth and glial migration from co-cultured hippocampal and septal slices into fibrin-fibronectin-containing matrix of peripheral regeneration chambers: A light and electron microscope study. Brain Res. 540:183-194; 1991.
23. Knoops, B.; Ponsar, C.; Hubert, I.; van den Bosch de Aguila, P. Regeneration of lesioned cholinergic septal neurons of the adult rat can be promoted by peripheral nerve grafts and a fibrin-fibronectin-containing matrix of peripheral regeneration chambers. Brain Res. Bull. 30: 433-437; 1993.
24. Knox, P.; Crooks, S.; Rimmer, C. Role of fibronectin in the migration of fibroblasts into plasma clots. J. Cell Biol. 102:2318-2323; 1986.
25. Krakow, W.; Endres, G.; Siegel, B.; Scheraga, H. An electron microscopic investigation of the polymerization of bovine fibrin monomer. J. Mol. Biol. 71:95-103; 1972.
26. Larsson, L.; Pach, J.; Brubaker, R. Aqueous humor dynamics in patients with diabetes mellitus. Am. J. Ophthalmol. 120:362-367; 1995.
27. Lin, L.-F.; Doherty, D.; Lile, J.; Bektesh, S.; Collins, F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132; 1993.
28. Malmfors, T. Studies on adrenergic nerves. The use of rat and mouse iris for direct observations on their physiology and pharmacology at cellular and subcellular levels. Acta Physiol. Scand. Suppl. 248:1-93; 1965.
29. Nair, C.; Dhall, D. Studies on fibrin network structure: The effect of some plasma proteins. Thromb. Res. 61:315-325; 1991.
30. Okada, M.; Blombäck, B.; Chang, M.; Horowitz, B. Fibronectin and fibrin gel structure. J. Biol. Chem. 260: 1811-1820; 1985.
31. Oppenheim, R.; Houenou, L.; Johnson,-J.; Lin, L.; Li, L.; Lo, A.; Newsome, A.; Prevette, D.; Wang, S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373:344-346; 1995.
32. 2-terminal fibrin-binding site of fibronectin. J. Biol. Chem. 269: 31938-31945; 1994.
33. Rovasio, R.; Delouvee, A.; Yamada, K.; Timpl, R.; Thiery, J. Neural crest cell migration: Requirements for exogenous fibronectin and high cell density. J. Cell Biol. 96:462-473; 1983.
34. Rowland, L.; Fink, M.; Rubin, L. Cerebrospinal fluid: Blood-brain barrier, brain edema, and hydrocephalus. In: Kandel, E.R.; Schwartz, J.H.; Jessell, T.M., eds. Principles of neural science. New York: Elsevier; 1991:1050-1060.
35. Sakharov, D.; Rijken, D. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 92: 1883-1890; 1995.
36. Sakharov, D.; Nagelkerke, J.; Rijken, D. Rearrangement of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. J. Biol. Chem. 271:2133-2138; 1996.
37. Strömberg, I.; Björklund, L.; Johansson, M.; Tomac, A.; Collins, F.; Olson, L.; Hoffer, B.; Humpel, C. Glial cell line-derived neurotrophic factor (GDNF) is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124: 401-412; 1993.
38. Tomac, A.; Lindqvist, E.; Lin, L.; Ögren, S.; Young, D.; Hoffer, B.; Olson, L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339; 1995.
39. Treanor, J.; Goodman, L.; Sauvage, F.D.; Stone, D.; Poulsen, K.; Beck, C.; Gray, C.; Armanini, M.; Pollock, R.; Hefti, F.; Phillips, H.; Goddard, A.; Moore, M.; Buj-Bello, A.; Davies, A.; Asai, N.; Takahashi, M.; Vandlen, R.; Henderson, C.; Rosenthal, A. Characterization of a multi-component receptor for GDNF. Nature 382:80-83; 1996.
40. Wilson, C.; Schwarzbauer, J. The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots. J. Cell Biol. 119:923-933; 1992.
41. Winn, S.; Hammang, J.; Emerich, D.; Lee, A.; Palmiter, R.; Baetge, E. Polymer/encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. USA 91:2324-2328; 1994.
42. Yang, Q.; Matheson, C.; Lopez, O. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344; 1995.